Legend Biotech Corporation
LEGN
$35.36
-$0.2693-0.76%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -325.33M | -218.15M | -177.03M | -348.13M | -285.01M |
| Total Depreciation and Amortization | 22.80M | 22.32M | 22.84M | 21.15M | 20.66M |
| Total Amortization of Deferred Charges | 520.00K | 520.00K | 520.00K | 768.00K | 953.00K |
| Total Other Non-Cash Items | 233.97M | 99.99M | 9.98M | 99.11M | 36.44M |
| Change in Net Operating Assets | -206.65M | -167.98M | -346.00K | 69.50M | 84.34M |
| Cash from Operations | -274.70M | -263.31M | -144.03M | -157.60M | -142.63M |
| Capital Expenditure | -15.67M | -9.86M | -14.11M | -16.07M | -19.38M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 348.02M | -187.89M | -836.44M | -339.12M | -873.96M |
| Cash from Investing | 332.35M | -197.76M | -850.54M | -355.19M | -893.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.14M | -4.04M | -4.02M | -2.78M | -3.34M |
| Issuance of Common Stock | 7.73M | 9.57M | 9.72M | 9.73M | 7.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.59M | 5.53M | 5.70M | 6.96M | 3.67M |
| Foreign Exchange rate Adjustments | 4.09M | -342.00K | -2.09M | 1.64M | 336.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.33M | -455.87M | -990.96M | -504.19M | -1.03B |